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Annual Report 
Development of Dose Coefficients for Radionulides Produced in 
Spallation Neutron Sources 
 
Research Staff:  Phillip W. Patton, Principal Investigator, Assistant Professor,   
                          Department of Health Physics 
                          Mark J. Rudin, Chair, Department of Health Physics 
 
Graduate Students: John P. Shanahan and Yayun Song 
 
DOE Collaborator:  Keith F. Eckerman, Oak Ridge National Laboratory 
 
Other Collaborators:  Faculty and students from Idaho State University, Georgia Institute 
of Technology, and Tbilisi State University, and faculty from the University of Florida. 
 
Goals and Background  
The University of Nevada, Las Vegas (UNLV) Transmutation Research Program has 
been tasked to support U.S. Department of Energy (DOE) efforts to assess the health 
risks associated with the operation of each of their accelerator-driven nuclear facilities for 
both NEPA and PSAR development.  Quantifying the radiological risks to workers will 
have to be addressed during the design and siting of each of these facilities. U.S. 
Environmental Protection Agency (EPA) Federal Guidance Report No. 11 “Limiting 
Values of Intake and Air Concentration and Dose Conversion Factors for Inhalation, 
Submersion, and Ingestion”, developed two derived guides, Annual Limit on Intake 
(ALI) and the Derived Air Concentration (DAC), to be used to control radiation exposure 
in the workplace.  The ALI is the annual intake of a radionuclide which would result in a 
committed effective dose equivalent of 0.05 Sv/yr for stochastic effects, or a committed 
dose equivalent to an individual organ or tissue of 0.5 Sv/yr for deterministic effects, to 
Reference Man (ICRP 1975).  A DAC is that concentration of a radionuclide in air 
which, if breathed by Reference Man for a work-year, would result in an intake 
corresponding to its ALI (EPA 1988).  Therefore, ALIs and DACs can be used for 
assessing radiation doses due to accidental ingestion and inhalation of radionuclides and 
are used for limiting radionuclide intake through breathing of, or submersion in, 
contaminated air. 
 
In addition to determining ALIs and DACs, in many situations it is useful to know the 
committed dose equivalent to an organ or tissue per unit intake, the committed effective 
dose equivalent per unit intake, the dose equivalent rate per unit air concentration of 
radionuclide, or the effective dose equivalent rate per unit air concentration of 
radionuclide. These dose coefficients (DCs) allow simple determination of radiation dose 
associated with various exposure scenarios, and ultimately, assess the health risks to 
workers in a nuclear facility. 
 
Even though the ALIs, DACs, and DCCs calculated in Federal Guidance Report No. 11 
adhere to the derived limits in Publication 30 (ICRP 1979), which incorporate current 
knowledge of radionuclide dosimetry and biological transport in humans, the report is not 
exhaustive in reference to anthropogenic radionuclides. Unfortunately, many of the rare 
radionuclides produced during the spallation process are not addressed in current 
radiation protection standards either. There may be as many as several hundred 
radionuclides that would be produced in either the target or blanket of proposed 
accelerator facilities for which no data exists in Federal Guide Report No. 11 or in 
Publications 68 and 72 of the ICRP.   
 
It is the intent of the current research to develop a methodology and generate internal and 
external dose coefficients for radionuclides produced in spallation neutron sources.  
Results from this study will expand the ALI and DAC data of Federal Guidance Report 
No. 11 in order to include radionuclides produced by current technology, such as that 
used in the AAA and SNS programs. 
 
Project Objectives 
There were four research objectives for Year 1 of this project: 
 
• to establish a research consortium comprised of representatives from 
several Universities and National Laboratories 
• to develop a prioritized list of radionuclides produced during the spallation 
process that will be considered as part of this study 
• to further Georgia Institute of Technology’s work on developing a 
reproducible methodology to determine internal and external DCs 
•  to generate internal and external DC values for selected radionuclides 
 
Research Accomplishments 
Each of the above project objectives were accomplished through the completion of 
specific tasks.  Completed tasks associated with each objective are identified below: 
 
Objective 1 – Establish a research consortium comprised of representatives from several 
Universities and National Laboratories 
 
Work performed under this project has continued to draw upon the experience and 
expertise residing at a number of respected health physics academic programs across the 
United States and representatives from DOE national laboratories. Faculty, and students 
from the following academic institutions are currently participants in the consortium: 
Georgia Institute of Technology, Idaho State University, University of Florida, and the 
University of Nevada, Las Vegas (UNLV).  Oak Ridge National Laboratory (ORNL) also 
has representation on the Consortium. 
 
Efforts were initiated in Year 1 to add representatives from other countries to serve as 
members on the TRP DC Consortium.  For example, faculty and students from Tbilisi 
State University in Tbilisi, Georgia have participated in a number of project activities and 
have been invited to formally become members of the Consortium.  Project personnel 
will continue to work to expand the number of participants and role of the existing TRP 
DC Consortium in a reasonable manner. 
 
A TRP DC Working Group was established in Year 1 to direct and oversee consortium 
activities.  The following individuals served as members of the Working Group in Year 
1: 
 
 Phillip Patton ,UNLV, Project Coordinator 
 Wesley Bolch, University of Florida 
 Richard Brey, Idaho State University 
Adam Arndt, Idaho State University 
Keith Eckerman, ORNL 
 Tom Gesell, Idaho State University  
Nolan Hertel, Georgia Tech 
Omar Wooten, Georgia Tech 
Samson Pagava, Tbilisi State University 
 Mark Rudin, UNLV 
 
The Project Coordinator was responsible for scheduling and hosting the two DC Working 
Group meetings in Las Vegas, NV (January and May 2002).  It should be emphasized 
that Working Group members and all participating members of the consortium worked 
collaboratively to complete all tasks associated with the project. UNLV personnel will 
host future working group meetings periodically to continually encourage collaboration 
and ensure project activities are completed in a timely manner.   
 
Objective 2 – Develop a prioritized list of radionuclides produced during the spallation 
process that will be considered as part of this study 
 
The DC Working Group decided initially to concentrate efforts to on generating DCs for 
those radionulcides that could be produced from the spallation of a liquid mercury target 
for which no DCs currently exist.  Over 520 radionuclides were identified as possible by 
product materials, all of which have the potential to be involved in various radiation 
exposure scenarios involving workers.  Prioritization of the 520 radionuclides included 
tabulating the list according to half-life and obtaining further physical information on 
each radionuclide (e.g., mode of decay, etc.), and determining which radionuclides 
currently have no DCs published in the literature.  The Working Group recommended 
focusing on thos radionuclides with half-lives between one and ten minutes.  
Radionuclides from the list with half-lives less than one minute and greater than ten 
minutes may be considered at a later date.  The prioritization effort identified 86 
radionuclides from the original list of 520 that will be considered for this phase of the 
project.  
 
Objective 3 - Further Georgia Institute of Technology’s work on developing 
a reproducible methodology to determine internal and external DCs 
 
The EDISTR computer code was initially developed to compile a nuclear decay database 
for internal radiation dosimetry calculations by the Biomedical Effects and 
Instrumentation Section of the Health and Safety Research Division of ORNL (Oak 
Ridge National Laboratory).  A methodology to take the output of EDISTR and generate 
nuclear decay data files suitably formatted for use by DCAL (Dose and Risk Calculation 
software) was developed by personnel from the Georgia Institute of Technology.  This 
methodology was later replaced by a series of MS-DOS executables found in the 
DECDAT (Decay Data) directory and introduced by Keith Eckerman at the student 
workshop.   
 
At the present tine the group has adopted the methodology used to develop Federal 
Guidance Report 13 from the U.S. Environmental Protection Agency (EPA).  In this 
methodology, relevant nuclear decay data is extracted from ENSDF (Evaluated Nuclear 
Structure Data File) and used by the computer code EDISTR to calculate mean energies 
and absolute intensities of all principal radiations associated with the radioactive decay of 
a radionuclide.  The executables of DECDAT arrange the output of EDISTR into the 
proper format for inclusion into the nuclear data libraries within DCAL.  DCAL consists 
of a series of computational modules for the calculation of dose and risk coefficients.  
The DCAL system also includes extensive libraries of biokinetic, anatomical, and 
dosimetric data representing the current state-of-the-art.  Specific information regarding 
each step of the methodology is presented in the Dose Coefficient (DC) Methodology 
Report that was developed as part of this project.  
 
Objective 4 - Generate internal and external DC values for selected radionuclides 
 
Internal dose coefficients for inhalation and ingestion scenarios were determined using 
the methodology described above for 5 of the 86 radionuclides identified by the DC 
Working Group. The five radionuclides selected for this report are presented in Table 1 
as well as the source of the nuclear decay data sets.  Source information can be found and 
is documented in the journal Nuclear Data Sheets. 
 
Table 1.  Radionuclides included for evaluation in current study. 
Ingestion and inhalation of particulates 
 
Atomic  Nuclide   Physical  Source of the 
Number      Half-Life  Nuclear Decay 
Data Set 
 
 
  26     Fe-61        5.98m     ENSDF 
 
  51     Sb-113     6.67m     ENSDF 
 
  55     Cs-123     5.94m     ENSDF 
 
  56     Ba-125     3.5m      ENSDF 
 
  62     Sm-139       2.57m     ENSDF 
 
 
The NUBASE database was utilized for these selected radionuclides to note primary and 
secondary decay chains, as well as, the status of an ENSDF for a particular radionuclide.  
This essentially allowed project personnel to identify “exotic” decay chains with 
complete decay data sets available for dose calculation purposes.  It also allowed  
personnel to compare the information in the ENSDF database to another database to 
identify missing or inaccurate information in the decay data sets.  Previous investigators 
(Endo and Yamaguchi 2001) effectively utilized this database to reexamine and update 
the decay data sets for the 817 radionuclides that are listed in ICRP Publication 38, 6 
additional isomers, and 162 additional radionuclides with half-lives ≥ 10 min. not listed 
in ICRP #38. 
 
The effective dose coefficients for workers for the five radionuclides are presented in 
Table 2.  The results are presented in the same format as ICRP Publications 68 and 72.   
It should be noted that the ICRP will report results to two significant figures and Table 2 
contains the output results from DCAL which are given in three significant figures.  As 
shown in Table 2, dose coefficients for inhalation of 1 µm and 5 µm particulates and 
ingestion are presented along with the f1 values and absorption types. 
 
Calculating external dose coefficients for environmental exposure scenarios for the 5 
selected radionuclides were not performed at this time.  The software version of DCAL 
did allow for these calculations to occur within the framework of the EXTCAL module 
but only for those radionuclides identified in FGR 13. In other words, these calculations 
could only be performed on those radionuclides included in the nuclear decay data 
libraries that came with the software package.  The user’s manual did provide instructions 
on how to calculate an external dose coefficient for radionuclides not listed in the nuclear 
decay data libraries once the appropriate data files were built (e.g. ICRP38.NDX, 
ICRP38.BET, and ICRP38.RAD).  Not included in this version of the software package 
was the example file EXTLIST.INP, which would allow the user to setup a template in 
order to carry out these calculations. 
 
Table 3 is a biokinetic comparison of current ICRP recommendations and the output form 
DCAL utilizing the ICRP 68 biokinetic subdirectory default parameters.  Inhalation and 
ingestion f1 values and absorption types are presented for the selected elements presented 
in this report.  As seen from the table several f1 values do not correspond to current ICRP 
recommendations. It is noted that DCAL does provide the user with the flexibility to 
define or update existing biokinetic subdirectories and utilize these parameters during 
calculations.  
 
 
 
 
 
 
 
 
 
Table 2.  Effective dose coefficients for Workers - Ingestion and inhalation of 
particulates 
 
Effective dose coefficient (Sv Bq-1) 
                      Inhalation, e inh (50)                    Ingestion   
 
Nuclide  t  Type  f1  1µmAMAD  5µmAMAD      f1               e ing (50) 
 
Iron 
Fe-61  5.98m     F 0.1   6.77E-12             1.14E-11     0.1         2.26E-11                              
     M 0.1         8.74E-12             1.44E-11 
     S 0.1         8.96E-12             1.48E-11  
 
Antimony 
Sb-113  6.67m    F 0.1   5.62E-12            9.54E-12         0.1      1.68E-11  
     M 0.01       7.41E-12      1.22E-11  
     S 0.1         7.65E-12            1.26E-11 
 
Cesium 
Cs-123  5.94m   F 1.0 5.62E-12             9.32E-12         1.0        1.96E-11 
     M 1.0         7.29E-12           1.19E-11 
     S 1.0         7.47E-12           1.21E-11 
 
Barium 
Ba-125 3.5m   F 0.1        4.91E-12    7.67E-12          0.1       7.41E-12 
     M 0.1        6.33E-12           9.68E-12  
     S 0.1        6.49E-12           9.90E-12  
 
Samarium 
Sm-139 2.57m   F 5E-4     3.00E-12          4.98E-12          5E-4     1.01E-11 
     M       5E-4     3.44E-12          5.69E-12 
     S        5E-4     3.49E-12          5.77E-12 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3.  Biokinetic comparison of f1 values:  ICRP versus DCAL output (\bio\i68). 
 
                  Inhalation                          Ingestion 
 
Nuclide         Publication          Type            ICRP   DCAL           ICRP    DCAL  
   
Iron     69       F  0.1 0.1   0.1 0.1 
                                                     M  0.1 0.1   
         S  0.01 0.1 
 
Antimony   69      F  0.1 0.1   0.1 0.1 
        M  0.01 0.01 
        S  0.01 0.1 
 
Cesium             56                      F  1.0 1.0   1.0 1.0 
       M  0.1 1.0  
        S  0.01 1.0 
 
Barium  67     F  0.2 0.1   0.2 0.1 
       M  0.1 0.1 
       S  0.01 0.1   
 
Samarium  30    All  5.0E-4 5.0E-4            5.0E-4  5.04E-4  
 
 
Data for 123Cs from the ENSDF and NUBASE databases are presented in Figures 1 and 2, 
respectively.  They are included in this report to illustrate the need to implement quality 
control measures to ensure the accuracy and credibility of the data.  It is noted from the 
figures that both ENSDF and NUBASE report different half-life and Q values for the 
same radionuclide.  These values are particularly important because EDISTR uses the Q-
value to compute the energy of an alpha particle and the end point energy of a beta 
particle.  It uses the half-life value to produce decay chain data as well as a reference to 
judge whether a daughter product is radioactive.  Previous work by Endo and 
Yamaguchi, 2001 updated an ENSDF decay data sets when the values of half-life, 
branching fraction, excitation energy, and total decay energy differed by more than 1% 
from those of NUBASE.   
 
 
 
 
 
 
 
 
 
 
 
123Xe 123Cs Electron Capture Decay 1981Ma01 199402
   
Published: 1993 Nuclear Data Sheets.  
123Cs Parent: Ex=0.0; Jπ=1/2+; T½=5.94 min 4; Qg.s.->g.s.=4210 50; %ε=100 
History 
Type 
 
Author Citation 
 
Cutoff Date
Full evaluation S. Ohya and T. Tamura Nuclear Data Sheets 70,531 (1993) 1-Jan-1993 
Figure 1.  ENSDF heading for Cs-123 EC decay data set.  Note t value of 5.94 min 
and a Q g.s.→g.s. value of 4210 KeV. 
 
 
Figure 2.  Radionuclide information sheet for Cs-123 from NUBASE.  Note t value 
of 5.87 min and a Q g.s.→g.s. value of 4202 KeV.  The reference (under Comm/Ref.) given 
for this radionuclide was the 1994 ENSDF. 
It is interesting to note that the NUBASE information sheet for this particular 
radionuclide sites ENSDF as the reference source and yet reports a different half-life and 
Q value.  In this particular case a more thorough evaluation of the literature would be 
required before a dose coefficient could be reported. 
 
 
Deliverables 
The following deliverables were completed during Year 1 of the project: 
 
DC Methodology Report (August 2002) 
Annual Report (September 2002)  
Professional Meeting Presentations/Publications (September 2002)  
 
Project Highlights 
• The research consortium, including Georgia Institute of Technology, Idaho State 
University, University, University of Florida, UNLV, Los Alamos National 
Laboratory (LANL), Oak Ridge National Laboratory (ORNL), and Tbilisi State 
University in Tbilisi, Republic of Georgia, was established.    
• A student workshop was hosted at UNLV to train graduate students from 
participating universities on the methodology of generating dose coefficients. 
 
 
• Researchers presented the “Development of Dose Conversion Coefficients for 
Radionuclides Produced in Spallation Neutron Sources” at the 47th Annual 
Bioassay, Analytical, and Environmental Radiochemistry Conference, Las Vegas 
in November 2001 and at the American Nuclear Society Winter Meting, Student 
Mini-Conference in Reno, NV November 2001. 
• “Development of Dose Conversion Coefficients for Radionuclides Produced in 
Spallation Neutron Sources” was presented as a poster at the Annual Meeting of 
the Health Physics Society, Tampa, FL June 2002. 
• Project personnel completed a report titled Dose Coefficient (DC) Methodology 
Report. 
• Project personnel used the DC methodology to generate internal DCs for 6 
radionuclides for which no DCs currently exist.  The results are presented in the 
Dose Coefficient (DC) Methodology Report. 
 
 
 
 
 
 
 
 
 
 
